BodyTite is a minimally invasive treatment that combines fat reduction with radiofrequency-assisted skin tightening
They do this by slowing down the emptying of the stomach into the small intestine, thus keeping food in the stomach for longer
Authoritative Sources New England Journal of Medicine phase 2 trial: published data on retatrutide dose groups, weight outcomes, and adverse events
A study of 72 adults with obesity found that those with the highest added sugar intake experienced the smallest increase in GLP-1 levels following glucose consumption
Limitations Side effects can be more pronounced initially (nausea, diarrhea)
Having cleared the hurdle as a treatment for diabetes, the FDA then approved semaglutide, marketed as Wegovy, for obesity in 2021, and then in Europe the following year